Charles Zhu
Stock Analyst at LifeSci Capital
(4.81)
# 498
Out of 5,073 analysts
313
Total ratings
57.9%
Success rate
20.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBIO Crescent Biopharma | Reiterated: Buy | $28 | $13.17 | +112.60% | 12 | Oct 5, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $18.00 | +122.22% | 22 | Oct 5, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $315 | $194.28 | +62.14% | 36 | Oct 5, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $46 | $19.10 | +140.84% | 7 | Oct 3, 2026 | |
| ADAG Adagene | Reiterated: Buy | $8 | $2.41 | +231.95% | 11 | Sep 29, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $34 | $28.12 | +20.93% | 30 | Sep 28, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $35.47 | +63.52% | 59 | Sep 27, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $0.8145 | - | 14 | Sep 22, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $32 | $15.60 | +105.13% | 2 | Sep 15, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $12 | $3.72 | +222.58% | 20 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $9.88 | +183.40% | 34 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $27.85 | +50.81% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $10.79 | +400.46% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $2.50 | +700.00% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.2314 | +764.30% | 8 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $5.90 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $26.98 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $20 | $3.59 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $31.43 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $39 | $25.16 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.376 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $26.08 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $20 | $1.36 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.41 | n/a | 1 | Nov 29, 2022 |
Crescent Biopharma
Oct 5, 2026
Reiterated: Buy
Price Target: $28
Current: $13.17
Upside: +112.60%
Immunome
Oct 5, 2026
Reiterated: Buy
Price Target: $40
Current: $18.00
Upside: +122.22%
Revolution Medicines
Oct 5, 2026
Reiterated: Buy
Price Target: $315
Current: $194.28
Upside: +62.14%
Arcus Biosciences
Oct 3, 2026
Reiterated: Buy
Price Target: $46
Current: $19.10
Upside: +140.84%
Adagene
Sep 29, 2026
Reiterated: Buy
Price Target: $8
Current: $2.41
Upside: +231.95%
Zymeworks
Sep 28, 2026
Reiterated: Buy
Price Target: $34
Current: $28.12
Upside: +20.93%
IDEAYA Biosciences
Sep 27, 2026
Reiterated: Buy
Price Target: $58
Current: $35.47
Upside: +63.52%
Compass Therapeutics
Sep 22, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8145
Upside: -
BlossomHill Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $15.60
Upside: +105.13%
Molecular Partners AG
Aug 25, 2026
Reiterated: Buy
Price Target: $12
Current: $3.72
Upside: +222.58%
Aug 13, 2026
Reiterated: Buy
Price Target: $28
Current: $9.88
Upside: +183.40%
Aug 13, 2026
Reiterated: Buy
Price Target: $42
Current: $27.85
Upside: +50.81%
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $10.79
Upside: +400.46%
Aug 11, 2026
Rated: Buy
Price Target: $26 → $20
Current: $2.50
Upside: +700.00%
Aug 8, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $0.2314
Upside: +764.30%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $5.90
Upside: n/a
May 24, 2024
Reiterated: Buy
Price Target: $14
Current: $26.98
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: $12 → $20
Current: $3.59
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $31.43
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: $45 → $39
Current: $25.16
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $5
Current: $0.376
Upside: n/a
Jan 3, 2023
Reiterated: Hold
Price Target: n/a
Current: $26.08
Upside: n/a
Jan 3, 2023
Reiterated: Buy
Price Target: $30 → $20
Current: $1.36
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.41
Upside: n/a